Últimas subidas - Macular Diseases - Acquired
|
Elmiron (pentasosan polysulfate) Macular Toxicityvista 159 veces77 year old female who had been on Elmiron for 20 years and stopped it 2 years agoMarzo 15, 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvista 135 veces77 year old female who had been on Elmiron for 20 years and stopped it 2 years agoMarzo 15, 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvista 151 veces77 year old female who had been on Elmiron for 20 years and stopped it 2 years agoMarzo 15, 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvista 76 veces77 year old female who had been on Elmiron for 20 years and stopped it 2 years agoMarzo 15, 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvista 77 veces77 year old female who had been on Elmiron for 20 years and stopped it 2 years agoMarzo 15, 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvista 94 veces77 year old female who had been on Elmiron for 20 years and stopped it 2 years agoMarzo 15, 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvista 94 veces77 year old female who had been on Elmiron for 20 years and stopped it 2 years agoMarzo 15, 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvista 98 veces77 year old female who had been on Elmiron for 20 years and stopped it 2 years agoMarzo 15, 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvista 66 veces77 year old female who had been on Elmiron for 20 years and stopped it 2 years agoMarzo 15, 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvista 94 veces77 year old female who had been on Elmiron for 20 years and stopped it 2 years agoMarzo 15, 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvista 95 veces77 year old female who had been on Elmiron for 20 years and stopped it 2 years agoMarzo 15, 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvista 110 veces77 year old female who had been on Elmiron for 20 years and stopped it 2 years agoMarzo 15, 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvista 108 veces77 year old female who had been on Elmiron for 20 years and stopped it 2 years agoMarzo 15, 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvista 103 veces77 year old female who had been on Elmiron for 20 years and stopped it 2 years agoMarzo 15, 2026
|
|
MacTel with foveal atrophy in both eyesvista 100 veces62 year old female with 20/50 OD, 20/40 OS.Febrero 18, 2026
|
|
MacTel with foveal atrophy in both eyesvista 72 veces62 year old female with 20/50 OD, 20/40 OS.Febrero 18, 2026
|
|
MacTel with foveal atrophy in both eyesvista 99 veces62 year old female with 20/50 OD, 20/40 OS.Febrero 18, 2026
|
|
MacTel with foveal atrophy in both eyesvista 107 veces62 year old female with 20/50 OD, 20/40 OS.Febrero 18, 2026
|
|
MacTel with foveal atrophy in both eyesvista 96 veces62 year old female with 20/50 OD, 20/40 OS.Febrero 18, 2026
|
|
MacTel with foveal atrophy in both eyesvista 101 veces62 year old female with 20/50 OD, 20/40 OS.Febrero 18, 2026
|
|
MacTel with foveal atrophy in both eyesvista 123 veces62 year old female with 20/50 OD, 20/40 OS.Febrero 18, 2026
|
|
MacTel with foveal atrophy in both eyesvista 85 veces62 year old female with 20/50 OD, 20/40 OS.Febrero 18, 2026
|
|
MacTel with foveal atrophy in both eyesvista 91 veces62 year old female with 20/50 OD, 20/40 OS.Febrero 18, 2026
|
|
MacTel with foveal atrophy in both eyesvista 90 veces62 year old female with 20/50 OD, 20/40 OS.Febrero 18, 2026
|
|
MacTel with foveal atrophy in both eyesvista 96 veces62 year old female with 20/50 OD, 20/40 OS.Febrero 18, 2026
|
|
MacTel with foveal atrophy in both eyesvista 94 veces62 year old female with 20/50 OD, 20/40 OS.Febrero 18, 2026
|
|
MacTel with foveal atrophy in both eyesvista 103 veces62 year old female with 20/50 OD, 20/40 OS.Febrero 18, 2026
|
|
MacTel with foveal atrophy in both eyesvista 88 veces62 year old female with 20/50 OD, 20/40 OS.Febrero 18, 2026
|
|
MacTel with foveal atrophy in both eyesvista 115 veces62 year old female with 20/50 OD, 20/40 OS.Febrero 18, 2026
|
|
Latanoprost induced CMEvista 137 veces89 year old man with CME from latanoprost that cleared within one month of stopping the medicationNoviembre 23, 2025
|
|
Latanoprost induced CMEvista 132 veces89 year old man with CME from latanoprost that cleared within one month of stopping the medicationNoviembre 23, 2025
|
|
Latanoprost induced CMEvista 127 veces89 year old man with CME from latanoprost that cleared within one month of stopping the medicationNoviembre 23, 2025
|
|
Latanoprost induced CMEvista 140 veces89 year old man with CME from latanoprost that cleared within one month of stopping the medicationNoviembre 23, 2025
|
|
Latanoprost induced CMEvista 153 veces89 year old man with CME from latanoprost that cleared within one month of stopping the medicationNoviembre 23, 2025
|
|
Latanoprost induced CMEvista 144 veces89 year old man with CME from latanoprost that cleared within one month of stopping the medicationNoviembre 23, 2025
|
|
Latanoprost induced CMEvista 129 veces89 year old man with CME from latanoprost that cleared within one month of stopping the medicationNoviembre 23, 2025
|
|
Latanoprost induced CMEvista 143 veces89 year old man with CME from latanoprost that cleared within one month of stopping the medicationNoviembre 23, 2025
|
|
Latanoprost induced CMEvista 125 veces89 year old man with CME from latanoprost that cleared within one month of stopping the medicationNoviembre 23, 2025
|
|
Latanoprost induced CMEvista 122 veces89 year old man with CME from latanoprost that cleared within one month of stopping the medicationNoviembre 23, 2025
|
|
Latanoprost induced CMEvista 134 veces89 year old man with CME from latanoprost that cleared within one month of stopping the medicationNoviembre 23, 2025
|
|
Latanoprost induced CMEvista 133 veces89 year old man with CME from latanoprost that cleared within one month of stopping the medicationNoviembre 23, 2025
|
|
Latanoprost induced CMEvista 150 veces89 year old man with CME from latanoprost that cleared within one month of stopping the medicationNoviembre 23, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 129 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 117 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 123 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 120 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 122 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 121 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 126 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 123 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 132 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 127 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 129 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 136 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 156 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 116 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 125 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 106 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 140 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Hydroxychloroquine Toxicityvista 152 veces60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OSDiciembre 22, 2024
|
|
Hydroxychloroquine Toxicityvista 184 veces60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OSDiciembre 22, 2024
|
|
Hydroxychloroquine Toxicityvista 193 veces60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OSDiciembre 22, 2024
|
|
Hydroxychloroquine Toxicityvista 176 veces60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OSDiciembre 22, 2024
|
|
Hydroxychloroquine Toxicityvista 159 veces60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OSDiciembre 22, 2024
|
|
Hydroxychloroquine Toxicityvista 157 veces60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OSDiciembre 22, 2024
|
|
Hydroxychloroquine Toxicityvista 160 veces60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OSDiciembre 22, 2024
|
|
Hydroxychloroquine Toxicityvista 208 veces60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OSDiciembre 22, 2024
|
|
Hydroxychloroquine Toxicityvista 215 veces60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OSDiciembre 22, 2024
|
|
Hydroxychloroquine Toxicityvista 172 veces60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OSDiciembre 22, 2024
|
|
Pseudophakic CME chronicvista 135 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 159 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 158 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 173 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 170 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 183 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 175 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 189 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 182 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 164 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 162 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 193 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 162 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 193 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 171 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 170 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 141 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 153 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 193 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 192 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 137 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 164 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevista 181 veces60 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OSSeptiembre 17, 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevista 177 veces60 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OSSeptiembre 17, 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevista 194 veces60 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OSSeptiembre 17, 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevista 190 veces60 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OSSeptiembre 17, 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevista 133 veces60 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OSSeptiembre 17, 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevista 164 veces60 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OSSeptiembre 17, 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevista 169 veces60 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OSSeptiembre 17, 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevista 184 veces60 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OSSeptiembre 17, 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevista 146 veces60 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OSSeptiembre 17, 2024
|
|
| 2319 archivos en 24 página(s) |
1 |
 |
|
|
|
|
|
|
|
|
|
